(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of 38.99% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.72%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.51%.
Carlsmed's revenue in 2026 is $56,438,000.On average, 8 Wall Street analysts forecast CARL's revenue for 2026 to be $2,081,713,429, with the lowest CARL revenue forecast at $1,987,707,931, and the highest CARL revenue forecast at $2,177,812,168. On average, 8 Wall Street analysts forecast CARL's revenue for 2027 to be $2,784,280,838, with the lowest CARL revenue forecast at $1,992,764,329, and the highest CARL revenue forecast at $3,097,179,417.
In 2028, CARL is forecast to generate $4,038,321,797 in revenue, with the lowest revenue forecast at $3,758,860,686 and the highest revenue forecast at $4,358,832,157.